Evozyne
Designs engineered protein therapeutics using an AI-native platform.
Company facts
- Founded
- 2020
- Employees
- 70
- Headquarters
- United States
- Type
- Private
- Funding
- Series B · $81M · 2023
Open positions
Talent Community | Data Scientist
Talent community posting (not a current opening) for Data Scientists at Evozyne, a Chicago startup engineering protein therapeutics with an AI-native platform. The role analyzes sequencing and assay data, builds statistical/ML models, and creates data pipelines to guide molecule design for immune-mediated diseases.
Director/Senior Director, Preclinical Program Leadership
Evozyne is an AI-native biotech company building a new way to design therapeutic proteins. Our generative AI platform was purpose-built to create entirely novel proteins that expand what’s possible beyond traditional…
Applied AI Research Fellow
Evozyne, an AI-native biotech in Chicago, seeks a research fellow to advance its EvoGen generative protein-design platform: benchmarking generative protein models, exploring Bayesian optimization extensions for multi-objective design, and building deep learning methods (VAEs, remote homology) validated against real experimental data.